Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Work In Process: 2024

Historic Work In Process for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $2.4 million.

  • Day One Biopharmaceuticals' Work In Process was N/A to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is N/A change from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Work In Process stood at $2.4 million for FY2024.
  • Day One Biopharmaceuticals' Work In Process' 5-year high stood at $2.4 million during FY2024, with a 5-year trough of $2.4 million in FY2024.
  • For the 1-year period, Day One Biopharmaceuticals' Work In Process averaged around $2.4 million, with its median value being $2.4 million (2024).